<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20210131050192N2</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-08-06</date_registration>
      <primary_sponsor>Najran University</primary_sponsor>
      <public_title>The Effect of Virtual Reality on Anxiety,  Stress, and Hemodynamic parameters among Primiparous Women During Cesarean Section: A Randomized controlled Clinical Trial</public_title>
      <acronym></acronym>
      <scientific_title>The Effect of Virtual Reality on Anxiety,  Stress, and Hemodynamic parameters among Primiparous Women During Cesarean Section: A Randomized controlled Clinical Trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-08-01</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>350</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/57814</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: The participants will be randomly assigned to intervention or control group through randomization block technique.  Six steps were followed to carryout participants' assignment using randomization block technique. First, the investigators will write a list contains numbers from 1 to 350. Second; the investigators will prepare small pieces of papers that comprise numbers from 1 to 350. Third; the investigators will fold each piece of papers to hide the written number, then it will be collected in a large bowl. Fourth; the researchers divided the 350 pieces of papers into 35 blocks in a random and blind manner. Each block contains 10. Fifth; from each block, five pieces of papers will be selected randomly and blindly to the intervention group and the remaining 5 pieces of papers will be assigned to the control group. A total of 175 numbers will be assigned to each group.  Sixth; the classification of cases will be recorded in the pre-prepared list (the word intervention or control will be recorded in front of each number) to be considered at the time of data collection. The intervention group (G1) included 175 participants and the control group (G2) involved 175 patients who will be submitted to routine care.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Caesarian section.</hc_freetext>
      <i_freetext>Intervention 1: For the intervention group, the virtual reality glass (VR) will be applied after regional anesthesia; then, hemodynamic parameters were assessed before intervention, immediately after anesthesia, skin incision, delivery, skin suture, and two hours after surgery. Anxiety will be reassessed at siting on surgery table, after completing skin suturing, and recovery time (2 hours postoperative). Stress will be reassessed after completing skin suture and two hours post-operative.  Women is also asked about her satisfaction about the care provided. Intervention 2: For the control group, they were left for routine hospital care. The same measurement timing for stress, anxiety, hemodynamic parameters neonatal APGAR score and maternal satisfaction about care provided were followed.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
published research report that contains all the study findings

When:
within one year and will be available long life

To whom:
public

Conditions:
for scientific use and public education

Where to obtain:
non

How to obtain:
non

Comments:
non</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Wafaa Taha Elgzar</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Elmashalia  Najran University campus</address>
        <city>Najran</city>
        <country1>Saudi Arabia</country1>
        <zip>66241</zip>
        <telephone>+966 17 542 8888</telephone>
        <email>wafaa.elgzar@nur.dmu.edu.eg</email>
        <affiliation>Najran University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Wafaa Taha Elgzar</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Elmashalia  Najran University campus</address>
        <city>Najran</city>
        <country1>Saudi Arabia</country1>
        <zip>66241</zip>
        <telephone>+966 17 542 8888</telephone>
        <email>wafaa.elgzar@nur.dmu.edu.eg</email>
        <affiliation>Najran University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Saudi Arabia</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Parturient with normal vision
Parturient with normal  hearing
No history of generalized anxiety disorder
No history of mental illness
Free from serious obstetrics complications (according to the obstetrician evaluation)
No increased intraoperative risk (e.g., placental disturbance) that identified in the preoperative period
Accept to participate on the study.</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>45 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Any woman developed intraoperative complication will be excluded from the study.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>O34.21</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Maternal care for scar from previous cesarean delivery</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>For the intervention group, the virtual reality glass (VR) will be applied after regional anesthesia; then, hemodynamic parameters were assessed before intervention, immediately after anesthesia, skin incision, delivery, skin suture, and two hours after surgery. Anxiety will be reassessed at siting on surgery table, after completing skin suturing, and recovery time (2 hours postoperative). Stress will be reassessed after completing skin suture and two hours post-operative.  Women is also asked about her satisfaction about the care provided.</i_keyword>
      <i_keyword>For the control group, they were left for routine hospital care. The same measurement timing for stress, anxiety, hemodynamic parameters neonatal APGAR score and maternal satisfaction about care provided were followed.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Stress. Timepoint: Stress will be reassessed after completing skin suture and two hours post-operative.  Women is also asked about her satisfaction about the care provided. Method of measurement: Part III: Emotional preoperative stress (B-MEPS)Caumo (2016) first developed this scale, it will be developed to measure the emotional preoperative stress.  It composed of 15 items, 3 of them rated on 4-point Likert scale, 11 of them rated on 3-point Likert scale and one of the have two answers. The high score indicates high stress.</prim_outcome>
      <prim_outcome>Anxiety. Timepoint: Anxiety will be reassessed at siting on surgery table, after completing skin suturing, and recovery time (2 hours postoperative). Method of measurement: Part: IV: A novel visual facial anxiety scale for assessing preoperative anxiety Cao et al, 2017 developed this scale. This Self-reported scale to measure anxiety during clinical practices. It composed of six faces that asses different degrees of anxiety from none (1), mild (2), mild-moderate (3), moderate (4), moderate-high (5) and highest (6). The highest score indicates high degree of anxiety.</prim_outcome>
      <prim_outcome>Hemodynamic parameters and fetal APGR score. Timepoint: hemodynamic parameters were assessed before intervention, immediately after anesthesia, skin incision, delivery, skin suture, and two hours after surgery. Method of measurement: Part II: Maternal hemodynamic parameters and newborn APGAR assessment sheet:The researchers developed this part after reviewing the current literature. This part will be used to register the maternal pulse, systolic, diastolic and mean blood pressure, respiratory rate and o2 saturation at patient admission, skin incision, delivery, skin suture and two hours after surgery. This part also contained questions about the incidence of nausea and drowsiness or vomiting. At the end of this part fetal APGAR sheet is present to asses at 1 and 5 minutes.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Najran University</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-04-25</approval_date>
        <contact_name>Najran University ethics committee</contact_name>
        <contact_address>Elmashalia  Najran University campus Najran Najran Saudi Arabia</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
